369 related articles for article (PubMed ID: 34525891)
21. Herpesviruses and SARS-CoV-2: Viral Association with Oral Inflammatory Diseases.
Banks JM; Capistrano KJ; Brandini DA; Zaidi F; Thakkar P; Rahat R; Schwartz J; Naqvi AR
Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251365
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
23. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
24. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
25. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
26. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
27. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
28. The "oral" history of COVID-19: Primary infection, salivary transmission, and post-acute implications.
Marchesan JT; Warner BM; Byrd KM
J Periodontol; 2021 Oct; 92(10):1357-1367. PubMed ID: 34390597
[TBL] [Abstract][Full Text] [Related]
29. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
31. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
32. Oral mucosal lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they a true sign of COVID-19 disease?
Cruz Tapia RO; Peraza Labrador AJ; Guimaraes DM; Matos Valdez LH
Spec Care Dentist; 2020 Nov; 40(6):555-560. PubMed ID: 32882068
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
34. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
Zawilska JB; Lagodzinski A; Berezinska M
J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
[TBL] [Abstract][Full Text] [Related]
35. Oral manifestations of COVID-19: Brief review.
Paradowska-Stolarz AM
Dent Med Probl; 2021; 58(1):123-126. PubMed ID: 33590976
[TBL] [Abstract][Full Text] [Related]
36. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
37. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.
Luke E; Swafford K; Shirazi G; Venketaraman V
Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
Wei J; Zhao J; Han M; Meng F; Zhou J
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
40. The spectrum of non-characteristic oral manifestations in COVID-19 - a scoping brief commentary.
Hüpsch-Marzec H; Dziedzic A; Skaba D; Tanasiewicz M
Med Pr; 2021 Dec; 72(6):685-692. PubMed ID: 34596170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
